GXO Logistics, Inc. (NYSE:GXO – Get Rating) – Analysts at Oppenheimer increased their FY2022 EPS estimates for GXO Logistics in a research note issued to investors on Sunday, May 8th. Oppenheimer analyst S. Schneeberger now anticipates that the company will post earnings of $2.78 per share for the year, up from their prior forecast of $2.71. Oppenheimer also issued estimates for GXO Logistics’ Q4 2022 earnings at $0.84 EPS and FY2023 earnings at $3.20 EPS. GXO Logistics (NYSE:GXO – Get Rating) last issued its quarterly earnings results on Wednesday, May 4th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.08. GXO Logistics had a net margin of 2.15% and a return on equity of 9.11%. The company had revenue of $2.08 billion during the quarter, compared to the consensus estimate of $2.06 billion. During the same period in the prior year, the company earned $0.37 EPS. GXO Logistics’s revenue was up 14.3% on a year-over-year basis.

Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) was downgraded by research analysts at TheStreet from a “b” rating to a “c” rating in a research note issued to investors on Friday, TheStreetRatingsTable reports.

Amgen (NASDAQ:AMGN – Get Rating) had its price target boosted by equities research analysts at Mizuho from $202.00 to $208.00 in a research note issued on Tuesday, The Fly reports. Mizuho’s price objective would suggest a potential downside of 13.06% from the stock’s current price.

Trex (NYSE:TREX – Get Rating) was upgraded by equities researchers at Credit Suisse Group from an “underperform” rating to a “neutral” rating in a research note issued to investors on Tuesday, The Fly reports.